Scroll down to discover
We have developed a unique and powerful combination of biomarker tests to support your therapeutic decision-making: next-generation sequencing of large gene panels, immunohistochemistry analysis and other tests performed on both solid and/or liquid biopsies.
OncoKDM is an online platform that turns your NGS data into actionable clinical information. Moreover, OncoKDM can integrate NGS results with IHC, MSI and TMB data. The resulting comprehensive and interactive report includes updated information about approved and investigational treatments for each patient, as well as NGS quality control data, patient clinical data and comprehensive NGS variants annotation.
Our platform OncoSHARE shows you the results of your patient's molecular profiling through an online integrated theranostic report that includes a comprehensive biological and clinical interpretation. This report gives you an insight into the most effective treatments according to the unique features of your patient's tumour, taking into account the most relevant scientific information, official cancer guidelines and recruiting clinical trials.
OncoDNA scientific team regularly publishes studies in peer-reviewed international journals. We have selected for you the key scientific publications that support our clinical expertise in precision oncology.
The clinical impact of using complex molecular profiling strategies in routine oncology practice ... [READ MORE]
Thanks to OncoDEEP, we were able to identify a new treatment that would have not been found from routine testing.
Precision medicine is becoming unavoidable for treating cancer. Each patient is unique, and there is a unique way to take care of him/her.
At OncoDNA, we believe in collaboration to ensure the delivery of personalised cancer care. Our latest projects include MDIP - the Molecular Diagnostic Innovation Partnership - and ONCOmmunity - the molecular oncology podcast. While MDIP aims to bring together care providers, payors, clinicians, nurses and patients to improve access to biomarker testing collectively; ONCOmmunity explores some aspects of molecular oncology in the treatment of cancer together with experts from various professional backgrounds and horizons.